Carbidopa: What Should I Discuss With My Healthcare Provider Before Taking Carbidopa

Content provided by Cerner Multum, Inc.

What should I discuss with my healthcare provider before taking carbidopa?

Do not take this medication without first talking to your doctor if you have

• taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or phenelzine (Nardil) in the past 2 weeks;
• narrow-angle glaucoma (angle closure glaucoma); or
• malignant melanoma (a type of skin cancer).

Before taking this medication, tell your doctor if you have

• heart disease, high blood pressure, arteriosclerosis, hardening of the arteries, a previous heart attack, or an irregular heartbeat;
• respiratory disease, including asthma and chronic obstructive pulmonary disease (COPD);
• liver disease;
• kidney disease;
• an endocrine (hormonal) disease;
• a stomach or intestinal ulcer;
• wide-angle glaucoma; or
• depression or any other psychiatric disorder.

You may need a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above.

It is not known whether carbidopa will be harmful to an unborn baby. Do not take carbidopa without first talking to your doctor if you are pregnant or could become pregnant during treatment.

It is also not known whether carbidopa will be harmful to a nursing infant. Do not take carbidopa without first talking to your doctor if you are breast-feeding a baby.

Last updated:	February 13, 2004